We systematically evaluated the characteristics of the PD-1/PD-L1 pathway in breast cancer, based on which we performed molecular classification of breast cancer and analyzed the clinical prognostic characteristics of different subtypes. This evidence concerns the gene PDCD1 and breast cancer.